FR2358892A1 - N(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide, ses derives - Google Patents

N(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide, ses derives

Info

Publication number
FR2358892A1
FR2358892A1 FR7622180A FR7622180A FR2358892A1 FR 2358892 A1 FR2358892 A1 FR 2358892A1 FR 7622180 A FR7622180 A FR 7622180A FR 7622180 A FR7622180 A FR 7622180A FR 2358892 A1 FR2358892 A1 FR 2358892A1
Authority
FR
France
Prior art keywords
benzamide
pyrrolidylmethyl
dimethoxy
allyl
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7622180A
Other languages
English (en)
French (fr)
Other versions
FR2358892B1 (US07652168-20100126-C00068.png
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ILE DE FRANCE ETUDES SCIENTIFIQU
Original Assignee
ILE DE FRANCE ETUDES SCIENTIFIQU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ILE DE FRANCE ETUDES SCIENTIFIQU filed Critical ILE DE FRANCE ETUDES SCIENTIFIQU
Priority to FR7622180A priority Critical patent/FR2358892A1/fr
Priority to CY1036A priority patent/CY1036A/xx
Priority to GB21883/77A priority patent/GB1539319A/en
Priority to BE1008238A priority patent/BE856289A/xx
Priority to MC771249A priority patent/MC1153A1/xx
Priority to OA56219A priority patent/OA05704A/xx
Priority to ZM54/77A priority patent/ZM5477A1/xx
Priority to PH19975A priority patent/PH12838A/en
Priority to AR268387A priority patent/AR214330A1/es
Priority to EG413/77A priority patent/EG12911A/xx
Priority to ES460621A priority patent/ES460621A1/es
Priority to GR53944A priority patent/GR60836B/el
Priority to YU1739/77A priority patent/YU40677B/xx
Priority to NZ184634A priority patent/NZ184634A/xx
Priority to CH867977A priority patent/CH627162A5/fr
Priority to SE7708176A priority patent/SE425243B/xx
Priority to AU27026/77A priority patent/AU509291B2/en
Priority to AT0511677A priority patent/AT365570B/de
Priority to PT66819A priority patent/PT66819B/pt
Priority to DD7700200091A priority patent/DD132492A5/xx
Priority to JP8552977A priority patent/JPS5338631A/ja
Priority to NO772530A priority patent/NO146598C/no
Priority to HU77SO1193A priority patent/HU174981B/hu
Priority to DD77207969A priority patent/DD137670A5/xx
Priority to MX775905U priority patent/MX4711E/es
Priority to LU77782A priority patent/LU77782A1/xx
Priority to IE1482/77A priority patent/IE46171B1/en
Priority to FI772214A priority patent/FI67213C/fi
Priority to IL52547A priority patent/IL52547A/xx
Priority to NLAANVRAGE7707982,A priority patent/NL174347C/xx
Priority to PL1977199723A priority patent/PL104244B1/pl
Priority to DK326377A priority patent/DK156646C/da
Priority to CS774811A priority patent/CS219885B2/cs
Priority to RO7791091A priority patent/RO71691A/ro
Priority to SU772504152A priority patent/SU695556A3/ru
Priority to IN1318/CAL/77A priority patent/IN146993B/en
Publication of FR2358892A1 publication Critical patent/FR2358892A1/fr
Priority to ZA00774256A priority patent/ZA774256B/xx
Application granted granted Critical
Publication of FR2358892B1 publication Critical patent/FR2358892B1/fr
Priority to IN457/CAL/79A priority patent/IN148039B/en
Priority to HK178/80A priority patent/HK17880A/xx
Priority to US06/540,918 priority patent/US4499019A/en
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7622180A 1976-07-19 1976-07-19 N(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide, ses derives Granted FR2358892A1 (fr)

Priority Applications (40)

Application Number Priority Date Filing Date Title
FR7622180A FR2358892A1 (fr) 1976-07-19 1976-07-19 N(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide, ses derives
CY1036A CY1036A (en) 1976-07-19 1977-05-24 N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoyolbenzamide and derivatives
GB21883/77A GB1539319A (en) 1976-07-19 1977-05-24 N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoylbenzamide and derivatives
BE1008238A BE856289A (fr) 1976-07-19 1977-06-30 N-(1'-allyle-2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide, ses derives
OA56219A OA05704A (fr) 1976-07-19 1977-07-05 Procédé de préparation de N (l'-allyl 2'-pyrrolidylméthyl) 2,3-diméthoxy 5-sulfamoyl benzamide.
MC771249A MC1153A1 (fr) 1976-07-19 1977-07-05 N-(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide,ses derives
ZM54/77A ZM5477A1 (en) 1976-07-19 1977-07-08 N(1'-allyl 2'-pyrrolidylmethyl) 2,3-dimethoxy 5-sulfamoyl benzamide, its derivatives
PH19975A PH12838A (en) 1976-07-19 1977-07-08 N-(1'-allyl 2'-pyrrolidylmethyl)2,3-dimet 5-sulfamoyl benzamide,it's derivatives
AR268387A AR214330A1 (es) 1976-07-19 1977-07-11 Procedimiento para la preparacion de n-(1'-alil-2'-pirrolidilmetil)-2,3-dimetoxi-5-sulfamoilbenzamida
EG413/77A EG12911A (en) 1976-07-19 1977-07-11 Process for preparing of n(1-allyl 2-pynolidy-methyl)2,3-dimethoxy 5-sulfamaylbenzamide its derivatives
ES460621A ES460621A1 (es) 1976-07-19 1977-07-11 Procedimiento de sintesis de n-(1'-alil-2'-pirrolidilmetil)-2,3-dimetoxi-5-sulfamoilbenzamida.
GR53944A GR60836B (en) 1976-07-19 1977-07-12 Preparation process of n-(i-alkyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoylbenzamide and derivatives thereof
YU1739/77A YU40677B (en) 1976-07-19 1977-07-13 Process for obtaininga n-(1'allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulfamoyl benzamides
NZ184634A NZ184634A (en) 1976-07-19 1977-07-13 N-(i'allyl-2-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoyl-benzamide and pharmaceutical compositions
CH867977A CH627162A5 (US07652168-20100126-C00068.png) 1976-07-19 1977-07-13
AU27026/77A AU509291B2 (en) 1976-07-19 1977-07-14 N-(1'-allyl 2'-pyrrolidylmethyl1) 2,3-dimethoxy 5-sulfamoylbenzamide derivatives
SE7708176A SE425243B (sv) 1976-07-19 1977-07-14 Forfarande for framstellning av n-(1'-alkyl-2'-pyrrolidylmetyl)-2,3-dimetoxi-5-sulfamoylbensamid med terapeutisk verkan
NO772530A NO146598C (no) 1976-07-19 1977-07-15 Analogifremgangsmaate for fremstilling av det terapeutisk aktive n-(1`-allyl-2`-pyrrolidylmetyl)-2,3-dimetoksy-5-sulfamoylbenzamider og derivater derav
DD7700200091A DD132492A5 (de) 1976-07-19 1977-07-15 Verfahren zur herstellung von n-(1-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulfamoylbenzamid und seinen derivaten
JP8552977A JPS5338631A (en) 1976-07-19 1977-07-15 Treating composition for nerve and sympathetic nerve disease group
AT0511677A AT365570B (de) 1976-07-19 1977-07-15 Verfahren zur herstellung des neuen n-(1'-allyl-2'-pyrrolidinylmethyl)-2,3-dimethox -5-sulfamoyl- benzamid, seinen saeureadditionssalzen, quartaeren ammoniumsalzen, seinem n-oxid sowie seinen opti- schen antipoden
HU77SO1193A HU174981B (hu) 1976-07-19 1977-07-15 Sposob poluchenija n-skobka-1-allil-2-pirrolidilmetil-skobka zakryta-2,3-dimetoksi-5-sul'famoil-benzamida i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
DD77207969A DD137670A5 (de) 1976-07-19 1977-07-15 Verfahren zur herstellung einer neuen pharmazeutischen zusammensetzung
MX775905U MX4711E (es) 1976-07-19 1977-07-15 Procedimiento para preparar derivados-be-n-(1-alil-2-pirrolidilmetil)-2-3-dimetoxi-5-sulfamoilbenzamida
LU77782A LU77782A1 (US07652168-20100126-C00068.png) 1976-07-19 1977-07-15
IE1482/77A IE46171B1 (en) 1976-07-19 1977-07-15 N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoylbenzamide and derivatives
PT66819A PT66819B (fr) 1976-07-19 1977-07-15 Procede de preparation de n-(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamida et ses derives
NLAANVRAGE7707982,A NL174347C (nl) 1976-07-19 1977-07-18 Werkwijze voor het bereiden van een farmaceutisch preparaat dat een (alkoxy-benzamide)-pyrrolidine bevat alsmede van een benzamidederivaat.
IL52547A IL52547A (en) 1976-07-19 1977-07-18 N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoylbenzamide its optical isomers its n-oxide and pharmaceutically acceptable salts thereof their preparation and pharmaceutical compoistions containing them
FI772214A FI67213C (fi) 1976-07-19 1977-07-18 Foerfarande foer framstaellning av terapeutiskt anvaendbar n-(1'-allyl-2'-pyrrolidylmetyl)-2,3-dimetoxi-5-sulfamoylbensamid
PL1977199723A PL104244B1 (pl) 1976-07-19 1977-07-18 Sposob wytwarzania n/1'-alkilo-2'-metylopirolidylo/-2,3-dwumetoksy-5-sulfamylobenzamidu i jego pochodnych
DK326377A DK156646C (da) 1976-07-19 1977-07-18 Analogifremgangsmaade til fremstilling af n-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulfamoyl-benzamid eller syreadditionssalte, kvaternaere ammoniumsalte, n-oxider eller optisk aktive isomere deraf
RO7791091A RO71691A (ro) 1976-07-19 1977-07-19 Procedeu pentru prepararea n-(1-alil-2-pirolidilmctil)-2,3-dimetoxi-5-sulfamoilbenzamidei
SU772504152A SU695556A3 (ru) 1976-07-19 1977-07-19 Способ получени -/1-аллил-2пирролидилметил/-2,3-диметокси-5сульфамоилбензамида или его солей
CS774811A CS219885B2 (en) 1976-07-19 1977-07-19 Method of making the n-lallyl-2-pyrolidylmethyl/-2,3-dimethoxy-5-sulphamoylbenzamide
IN1318/CAL/77A IN146993B (US07652168-20100126-C00068.png) 1976-07-19 1977-08-23
ZA00774256A ZA774256B (en) 1976-07-19 1978-05-12 N(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide,its derivatives
IN457/CAL/79A IN148039B (US07652168-20100126-C00068.png) 1976-07-19 1979-05-04
HK178/80A HK17880A (en) 1976-07-19 1980-04-03 N-(1'-allyl-2'-pyrrolidylmethyl)-2-3-dimethoxy-5-sulphamoylbenzamide and derivatives
US06/540,918 US4499019A (en) 1976-07-19 1983-10-13 N-(1-allyl-2-pyrrolidylmethyl)-2,3-dimethoxy-5-sulfamoylbenzamide and derivatives thereof and method for treating hot flushes associated with natural or surgical menopause

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7622180A FR2358892A1 (fr) 1976-07-19 1976-07-19 N(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide, ses derives

Publications (2)

Publication Number Publication Date
FR2358892A1 true FR2358892A1 (fr) 1978-02-17
FR2358892B1 FR2358892B1 (US07652168-20100126-C00068.png) 1978-12-15

Family

ID=9175947

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7622180A Granted FR2358892A1 (fr) 1976-07-19 1976-07-19 N(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide, ses derives

Country Status (38)

Country Link
US (1) US4499019A (US07652168-20100126-C00068.png)
JP (1) JPS5338631A (US07652168-20100126-C00068.png)
AR (1) AR214330A1 (US07652168-20100126-C00068.png)
AT (1) AT365570B (US07652168-20100126-C00068.png)
AU (1) AU509291B2 (US07652168-20100126-C00068.png)
BE (1) BE856289A (US07652168-20100126-C00068.png)
CH (1) CH627162A5 (US07652168-20100126-C00068.png)
CS (1) CS219885B2 (US07652168-20100126-C00068.png)
CY (1) CY1036A (US07652168-20100126-C00068.png)
DD (2) DD137670A5 (US07652168-20100126-C00068.png)
DK (1) DK156646C (US07652168-20100126-C00068.png)
EG (1) EG12911A (US07652168-20100126-C00068.png)
ES (1) ES460621A1 (US07652168-20100126-C00068.png)
FI (1) FI67213C (US07652168-20100126-C00068.png)
FR (1) FR2358892A1 (US07652168-20100126-C00068.png)
GB (1) GB1539319A (US07652168-20100126-C00068.png)
GR (1) GR60836B (US07652168-20100126-C00068.png)
HK (1) HK17880A (US07652168-20100126-C00068.png)
HU (1) HU174981B (US07652168-20100126-C00068.png)
IE (1) IE46171B1 (US07652168-20100126-C00068.png)
IL (1) IL52547A (US07652168-20100126-C00068.png)
IN (1) IN146993B (US07652168-20100126-C00068.png)
LU (1) LU77782A1 (US07652168-20100126-C00068.png)
MC (1) MC1153A1 (US07652168-20100126-C00068.png)
MX (1) MX4711E (US07652168-20100126-C00068.png)
NL (1) NL174347C (US07652168-20100126-C00068.png)
NO (1) NO146598C (US07652168-20100126-C00068.png)
NZ (1) NZ184634A (US07652168-20100126-C00068.png)
OA (1) OA05704A (US07652168-20100126-C00068.png)
PH (1) PH12838A (US07652168-20100126-C00068.png)
PL (1) PL104244B1 (US07652168-20100126-C00068.png)
PT (1) PT66819B (US07652168-20100126-C00068.png)
RO (1) RO71691A (US07652168-20100126-C00068.png)
SE (1) SE425243B (US07652168-20100126-C00068.png)
SU (1) SU695556A3 (US07652168-20100126-C00068.png)
YU (1) YU40677B (US07652168-20100126-C00068.png)
ZA (1) ZA774256B (US07652168-20100126-C00068.png)
ZM (1) ZM5477A1 (US07652168-20100126-C00068.png)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2438650A1 (fr) * 1978-10-11 1980-05-09 Ile De France N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire
FR2478093A1 (fr) * 1980-03-12 1981-09-18 Ile De France Nouveau procede de preparation de n-(1-alkyl (ou allyl) 2-pyrrolidinyl-methyl)2-methoxy (ou 2,3-dimethoxy) 5-sulfamoyl (ou sulfamoyl substitue)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5639431A (en) * 1979-09-06 1981-04-15 Susumu Yagyu Colorimeter having two-light pass length and two-wave length
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2584605B1 (fr) * 1985-07-15 1988-06-17 Ile De France Application du n-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide dans le traitement de la maladie de parkinson
US7645750B2 (en) * 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
US8420624B2 (en) * 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations
CN105481733A (zh) * 2015-12-30 2016-04-13 苏州诚和医药化学有限公司 一种一步法合成2-甲氧基-5-氨磺酰基苯甲酸甲酯的方法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2438650A1 (fr) * 1978-10-11 1980-05-09 Ile De France N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire
FR2478093A1 (fr) * 1980-03-12 1981-09-18 Ile De France Nouveau procede de preparation de n-(1-alkyl (ou allyl) 2-pyrrolidinyl-methyl)2-methoxy (ou 2,3-dimethoxy) 5-sulfamoyl (ou sulfamoyl substitue)

Also Published As

Publication number Publication date
AU509291B2 (en) 1980-05-01
CH627162A5 (US07652168-20100126-C00068.png) 1981-12-31
CY1036A (en) 1980-08-01
DD132492A5 (de) 1978-10-04
PH12838A (en) 1979-09-05
FI67213C (fi) 1985-02-11
FI67213B (fi) 1984-10-31
DD137670A5 (de) 1979-09-19
RO71691A (ro) 1982-09-09
NO146598C (no) 1982-11-03
IE46171B1 (en) 1983-03-23
AU2702677A (en) 1979-01-18
SE7708176L (sv) 1978-01-20
ES460621A1 (es) 1978-05-01
DK156646C (da) 1990-02-05
NL174347C (nl) 1984-06-01
FI772214A (US07652168-20100126-C00068.png) 1978-01-20
SE425243B (sv) 1982-09-13
PL199723A1 (pl) 1978-04-24
PL104244B1 (pl) 1979-08-31
ATA511677A (de) 1981-06-15
PT66819B (fr) 1978-12-22
ZM5477A1 (en) 1978-05-22
ZA774256B (en) 1978-06-28
AR214330A1 (es) 1979-05-31
IL52547A0 (en) 1977-10-31
US4499019A (en) 1985-02-12
AT365570B (de) 1982-01-25
OA05704A (fr) 1981-05-31
NL174347B (nl) 1984-01-02
IL52547A (en) 1980-01-31
NO772530L (no) 1978-01-20
YU40677B (en) 1986-04-30
JPS554724B2 (US07652168-20100126-C00068.png) 1980-01-31
NO146598B (no) 1982-07-26
MC1153A1 (fr) 1978-04-17
JPS5338631A (en) 1978-04-08
NZ184634A (en) 1978-11-13
SU695556A3 (ru) 1979-10-30
IE46171L (en) 1978-01-19
HK17880A (en) 1980-04-11
CS219885B2 (en) 1983-03-25
IN146993B (US07652168-20100126-C00068.png) 1979-10-20
NL7707982A (nl) 1978-01-23
DK326377A (da) 1978-01-20
BE856289A (fr) 1977-12-30
GB1539319A (en) 1979-01-31
EG12911A (en) 1980-12-31
MX4711E (es) 1982-08-11
DK156646B (da) 1989-09-18
GR60836B (en) 1978-08-31
HU174981B (hu) 1980-04-28
LU77782A1 (US07652168-20100126-C00068.png) 1977-10-17
PT66819A (fr) 1977-08-01
YU173977A (en) 1983-01-21
FR2358892B1 (US07652168-20100126-C00068.png) 1978-12-15

Similar Documents

Publication Publication Date Title
ES2040242T3 (es) Composiciones farmaceuticas.
NO170280C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfamatderivater
BG49825A3 (en) Method for preparing of 10- dihydro- 10- deoxo- 11- asaeritronolides a
ES2066864T3 (es) Derivados de aralquilamina y fungicidas que los contienen.
NO178923C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 24-homo-vitamin-D-derivater
BG92179A (bg) Метод за получаване на 7-заместена-хепт-6-еноена и -хептаноена киселина и техни производни и междинни съединения
FR2391723A1 (fr) Composition therapeutique a base de cetone aliphatique pour le traitement des ulceres peptiques
BE898749A (fr) Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic
FR2358892A1 (fr) N(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide, ses derives
FR2440946A2 (fr) Nouveaux benzamides heterocycliques substitues, leurs procedes de preparation et leur application comme modificateurs du comportement
NO164166C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazoletanolestere.
FR2374903A1 (fr) Nouvelle association utilisable en medecine veterinaire
FR2457689A1 (fr) Medicament hypolipemique a base de carnitine
FR2361877A1 (fr) Nouvelles lactones d'acides libres du type prostaglandine, leur preparation et medicament les contenant
FR2376150A1 (fr) Compositions therapeutiques a base de derives de l'hexahydro-1,2,3,3a,4,5-canthine
FR2375222A1 (fr) Nouveaux composes du type (2-benzothiazolyl)oxamate, leur procede de preparation et medicament les contenant
ES2041815T3 (es) Un procedimiento para la obtencion de derivados de ornitina 5-sustituidos.
ES8106516A1 (es) Procedimiento de preparacion de nuevos derivados halovinca- monas y de sus sales de adicion acidas farmaceuticamente aceptables e isomeros opticamente activos de los mismos
BG96487A (bg) Р-заместени производни на 4-оксибутанамина,методи за получаването им и тяхното приложение
PT82547B (pt) Processo de preparacao de acidos hexenoicos e de composicoes farmaceuticas que os contem
GB1514389A (en) Glycerides with antibacterial properties
FR2369837A1 (fr) Derives actifs de l'uree, leur procede de preparation ainsi que les compositions therapeutiques les contenant
FR2430230A1 (fr) Medicaments a base de derives de l'acide anthranilique
FR2429219A1 (fr) Medicament a base de derives de la thienopyridone ou de la furopyridone
FR2395251A1 (fr) Acide phenylglycolique substitue, sels et esters pharmaceutiquement acceptables de celui-ci et procedes de preparation

Legal Events

Date Code Title Description
CL Concession to grant licences
CL Concession to grant licences
CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0158, 920505

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0158, 760719

CL Concession to grant licences
TP Transmission of property